We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
US Anxiety and Depression Treatment Outlook 2023-2028 Study
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 90 days · 90 data points
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 90 days • 1 price levels
Price Analysis
Most common price: £520 (90 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 90 days
Description
Key Features
Provides a detailed outlook for anxiety disorders and depression treatments in the United States from 2023 through 2028.
Includes latent demand estimates in millions of U.S. dollars to identify potential industry earnings across the country.
Covers data for approximately 12,600 cities to offer a wide-reaching view of the treatment market.
Offers comparative benchmarks by reporting the percent share of each city relative to its state and the entire United States.
Supports the development of distribution and sales force strategies through a detailed statistical approach.
Product Specifications
- Format
- paperback
- ASIN
- B0BLQYK3T1
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
Anxiety and Depression Outlook 2023-2028 - ICON Group
Anxiety Disorder Treatments Outlook 2023-2028 - ICON Group
Anxiety Disorder Therapeutics Outlook 2023-2028 - US Study
US Antidepressants for Anxiety Disorders Outlook 2023-2028
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs
Antidepressants for Major Depressive Disorders Outlook 2023-2028
The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan
US Stress Management Treatment Outlook 2023-2028 Report
India Stress Management Treatment Outlook 2023-2028 Study
The 2026-2031 World Outlook for Antidepressant Drugs
The 2026-2031 World Outlook for Antidepressants
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in China
The 2021-2026 World Outlook for Antidepressants
The 2026-2031 World Outlook for Antidepressant Pharmaceuticals
The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics
Price unavailable
The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders
Personal Therapy Products US Outlook 2023-2028 Study
Anxiety Disorders: From Childhood to Adulthood
IntechOpen
The 2023-2028 World Outlook for Stress Management Treatments
Anxiety and Depression in Primary Care: International Perspectives (WONCA Family Medicine)
CRC Press
Treatments for Anxiety: Fact versus Fiction
Bloomsbury
Antidepressants for Major Depressive Disorders Outlook 2023-2028
The Self in Anxiety, Stress and Depression
North Holland